Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

HFRX Global Hedge Fund Index posts decline of -1.69% in May (1.52% YTD)

Tuesday, June 05, 2012
Opalesque Industry Update - Global equity markets declined sharply in May as European sovereign debt and bank liquidity concerns resulted in a sharp increase in investor risk aversion; mixed economic data in US and disappointing results of large technology IPO also contributed to investor concerns. Equities in Energy, Technology, Financials and Emerging Markets all posted sharp declines for May 2012. Treasury yields in safe haven countries fell to historical lows with gains in longer dated issues contributing to significant curve flattening. Investors flocked to US dollar & Swiss Franc, driving these to strong gains against the Euro. Commodities also posted declines on a weakening global economic outlook, with Oil and Copper posting large declines.

Hedge funds posted declines for the month with Macro strategy gains partially offsetting Equity strategy declines; the HFRX Global Hedge Fund Index posted a decline of -1.69% while the HFRX Absolute Return Index posted a narrow decline of -0.24%.

The HFRX Macro CTA Index gained +0.36% in May with strong positive contributions from systematic diversified funds, partially offset by mixed performance across discretionary and commodity strategies. The HFRX Macro Systematic Diversified CTA Index led all hedge fund strategies in May, posting a gain of +2.81%, the strongest performance since July 2011. Constituent managers posted gains as a result of currency positions, including Long US$/Euro, and significant positions in government fixed income. Discretionary & Commodity focused managers posted mixed performance across the various asset classes in a volatile month.

The HFRX Equity Hedge Index posted a decline of -3.07%, its largest decline in since September 2011, as global equity markets posted steep declines. The HFRX Equity Market Neutral Index posted a decline of -0.44% for the month, with gains across trading and factor-based strategies offset by weakness in behavioral strategies. Fundamental Growth and Fundamental Value declined -3.60% and -1.92%, respectively, with Technology, Energy & Financials all contributing to declines.

The HFRX Relative Value Arbitrage Index posted a decline of -1.65%, the first monthly decline in 6 months, with credit & equity losses only partially offset by falling yields and increased volatility. The HFRX Convertible Arbitrage Index posted a decline of -0.65% for the month, the 1st monthly decline for 2012, with credit losses offsetting gains from short equity, volatility and falling yields. The HFRX RV Multi-Strategy Index declined -1.58%, with weakness across Fixed Income Arbitrage & Energy Infrastructure exposures only partially offset by mixed performance across Emerging Markets exposures.

The HFRX Event Driven Index posted a decline of -2.01% for the month, with May weakness only narrowing the YTD gain to +3.6%. The HFRX Merger Arbitrage Index posted a decline of -0.21% for the month, with positions in Johnson & Johnson, Motorola Mobility, Viterra & Glencore, Kinder Morgan and El Paso contributing to results. Despite a positive contribution from Credit Arbitrage strategies, equity and distressed strategies posted declines for the month, with HFRX Special Situations Index and the HFRX Distressed Index declining by -2.34% and -1.41%, respectively.

Comments reference performance figures for May 31, 2012

(press release)

Performance table: www.hedgefundresearch.com

BG

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its